This article first appeared on GuruFocus.
Cathie Wood’s ARK Invest increased its exposure to artificial intelligence, digital assets and next-generation healthcare during the week of June 22 to 26, while reducing positions in streaming and Chinese technology companies.
ARK Invest added to several AI-related holdings, including Cerebras Systems (NASDAQ:CBRS), CoreWeave (NASDAQ:CRWV), Tesla (NASDAQ:TSLA), Alphabet (GOOG), Palantir Technologies (NASDAQ:PLTR) and Amazon (AMZN). The firm also expanded its position in SpaceX (NASDAQ:SPCX) across multiple funds and increased investments in crypto-linked companies such as Circle Internet Group (NYSE:CRCL), Coinbase Global (NASDAQ:COIN), Robinhood Markets (HOOD) and Bullish (BLSH).
In healthcare, ARK Invest increased stakes in Recursion Pharmaceuticals (RXRX), Generate Biomedicines (GENB), Tempus AI (TEM), Alamar Biosciences (NASDAQ:ALMR) and Eli Lilly (NYSE:LLY), reflecting continued interest in AI-driven drug discovery and precision medicine.
On the selling side, ARK Invest made its largest reduction in Roku (ROKU) while also trimming holdings in Alibaba Group (NYSE:BABA), Baidu (NASDAQ:BIDU), Absci (ABSI), Strata Critical Medical (SRTA) and Twist Bioscience (TWST) as part of its ongoing portfolio rebalancing.